With adequate funding, research and pharmacovigilance, these efforts can be realized and can improve gender equity in the safe and effective delivery of treatments for both males and females, particularly in low-income, malaria-endemic areas, where both malaria and G6PD deficiencies have the greatest impact on women and their families. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.